IRCT20230312057688N1
Recruiting
Phase 2
evaluation of the effect of gasteroesophageal reflux treatment on improving pulmonary function in patients with cystic fibrosis
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Cystic Fibrosis.
- Sponsor
- Ahvaz University of Medical Sciences
- Enrollment
- 20
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Cystic fibrosis patients over 6 years old
- •Not having advanced respiratory disease
Exclusion Criteria
- •patients treated with proton pump inhibitors
- •patients with severe pulmonary disease
- •non adherence to pulmonary treatments
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
The differential effect of gastroesophageal reflux disease on laryngo-hypopharyngeal mechanosensitivity and chemosensitivity.ACTRN12610000449033niversity of Sydney30
Recruiting
Not Applicable
Assessment of gastroesophageal reflux in patients without reflux symptomsGastroesophageal reflux diseaseJPRN-UMIN000043956Tohoku University23
Not yet recruiting
Not Applicable
Thorcolumbar Kyphosis Patients With GERDthe GERD OccurenceNCT04521985National Taiwan University Hospital30
Completed
Not Applicable
Examination study of the gastroesophageal reflux disease improvement effect by Vonoprazan to the patients with systemic sclerosisJPRN-UMIN000024236Department of Gastroenterology Nagasaki University Hospital20
Recruiting
Not Applicable
Evaluation of gastroesophageal reflux using high-resolution manometry and pH monitor after proximal gastrectomygastric cancerJPRN-UMIN000040514The University of Tokyo30